COMPANY

Monod Bio

HQ: Seattle, WA source · monod.bio ↗ · West Coast

Monod Bio is developing de novo protein binders that provide for sensitive detection of proteins, peptides, and small molecules. From company website Source · Oct 13, 2026

Keywords: small molecules peptides diagnostics in vitro diagnostics

Profile checked Oct 10, 2026

3NIH grants

NIH awards 3

Annual award amounts. Total $998K.

Aug 3, 2026 NIH award 1R44GM161195-01A1 FY2026: $377,260 awarded for that fiscal year; activity R44 (SBIR); PI QUIJANO RUBIO, ALFREDO; recipient as written: MONOD BIO, INC., SEATTLE, WA. Design of rapid and quantitative biosenso source ↗
Jul 23, 2026 NIH award 1R43GM163512-01 FY2026: $330,955 awarded for that fiscal year; activity R43 (SBIR); PI QUIJANO RUBIO, ALFREDO; recipient as written: MONOD BIO, INC., SEATTLE, WA. Computational Protein Design of Robust and source ↗
Dec 26, 2023 NIH award 1R43TR004888-01 FY2024: $290,066 awarded for that fiscal year; activity R43 (SBIR); PI QUIJANO RUBIO, ALFREDO; recipient as written: MONOD BIO, INC., SEATTLE, WA. Novel Biosensor for Detection of Endotoxin source ↗

Funding and NIH signals

NIH award NIH awarded $377K (SBIR Phase II 1R44GM161195-01A1, new, notice Aug 3, 2026); 2 NIH awards totaling $708K in the last 12 months. NIH RePORTER 1R44GM161195-01A1 (Aug 3, 2026)
Evidence (2 events)
- Aug 3, 2026 · NIH RePORTER 1R44GM161195-01A1
  Organization: MONOD BIO, INC.; City/State: SEATTLE, WA; Project number: 1R44GM161195-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-03; FY total cost (award amount): 377260; Administering IC: National Institute of General Medical Sciences; Project title: Design of rapid and quantitative biosensors with computational protein design; Organization type: Domestic For-Profits
- Jul 23, 2026 · NIH RePORTER 1R43GM163512-01
  Organization: MONOD BIO, INC.; City/State: SEATTLE, WA; Project number: 1R43GM163512-01; Activity code: R43; Fiscal year: 2026; Award notice date: 2026-07-23; FY total cost (award amount): 330955; Administering IC: National Institute of General Medical Sciences; Project title: Computational Protein Design of Robust and Scalable Recombinant HRP and Poly-HRP Reagents; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals